Healthcare · Medical Instruments & Supplies · United States
As of 2026-04-17 · Source: yfinance · Market: closed_weekend · Cache TTL 360 min
| 1 Day | +2.40% |
| 1 Month | +0.29% |
| 3 Months | +0.07% |
| YTD | +3.45% |
| 1 Year | +2.57% |
| 52-Week High | $187.35 |
| 52-Week Low | $127.59 |
| Market Cap | $57,438,265,344 |
| P/E (Trailing) | 25.91 |
| P/E (Forward) | 11.74 |
| EPS (TTM) | $6.12 |
| Dividend Yield | 2.65% |
| Beta | 0.35 |
| Revenue (TTM) | $21,923,999,744 |
| Profit Margin | 8.01% |
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow system, automated medication dispensing and supply management systems, informatics and analytics and pharmacy automation system, and medication inventory optimization and tracking system; hemodynamic monitoring system; and prefillable drug delivery systems. It also offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, and microorganism identification and drug susceptibility, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, an